The U.S. Justice Department had claimed Abbott paid prominent physicians for speaking engagements and teaching assignments with the expectation the physicians would arrange for the hospitals with which they are affiliated to purchase Abbott products. As a result, the federal government claimed Abbott violated the Anti-Kickback Statute. The government also alleged procedures performed using the Abbott products should not have been billed to Medicare under the False Claims Act.
The suit was instigated by two whistle-blowing former Abbott employees, who will receive a total of more than $1 million of the settlement under the whistle-blower provision of the False Claims Act.
More Articles on Healthcare Settlements:
DOJ Recovers $2.6B From Healthcare False Claims Act Cases
GlaxoSmithKline to Halt Payments to Physicians for Drug Promotions
St. Elizabeth Hospital Fined $10k for Improper Hazardous Waste Storage
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
